November 01, 2022
October 18, 2022
March 22, 2024
The osteoarthritis market size is projected to boost from USD 8.60 billion in 2023 to reach around USD 19.15 billion in 2032 with an 8.4% CAGR over the forecast period 2024 to 2032. Report Highlights: Knee osteoarthritis being the most prevalen...
March 21, 2024
The respiratory drugs market size is estimated to grow from 16.57 billion in 2023 to reach around USD 28.11 billion by 2032, registering a CAGR of 5.8% between 2024 and 2032. Report Highlights Chronic Obstructive Pulmonary Disease (COPD) being ...
March 19, 2024
The cervical spondylosis diagnosis and treatment market size is estimated to grow from USD 6.21 billion in 2023 to around USD 11.83 billion by 2032, registering a CAGR of 6.7% between 2024 and 2032. Report Highlights: Medications dominated the ...
March 18, 2024
The alopecia areata market size is estimated to grow from USD 3.09 billion in 2023 to around USD 6.30 billion by 2032, registering a CAGR of 7.6% between 2024 and 2032. Report Highlights: Medication treatments exhibited the largest 70% market s...
March 15, 2024
The non-steroidal anti-inflammatory drugs market size is estimated to grow from USD 21.01 billion in 2023 to around USD 33.55 billion by 2032, registering a CAGR of 5.0% between 2024 and 2032. Report Highlights: Arthritis, an inflammatory bone ...
March 14, 2024
The HIV drugs market size is estimated to grow from USD 33.32 billion in 2023 to surpass around USD 49.68 billion by 2032, registering a CAGR of 4.3% between 2024 and 2032. Report Highlights: Combination-class drugs dominated the market in 2023...
March 13, 2024
The global alzheimer’s therapeutics market size is estimated to grow from USD 4.82 billion in 2023 to surpass around USD 8.18 billion by 2032, registering a CAGR of 8.7% between 2024 and 2032. Report Highlights Cholinesterase inhibitors l...
March 11, 2024
The nanomedicine market size achieved a value of USD 219.34 billion in 2023 and is anticipated to reach USD 562.93 billion by 2032, registering a CAGR of 10.1% from 2024 to 2032. Report Highlights: Clinical oncology indication leads the pack, d...
February 29, 2024
The rheumatoid arthritis drugs market size achieved a value of USD 17.87 billion in 2023 with this trajectory, it is expected to reach USD 27.38 billion by 2033. Projected growth indicates a compound annual growth rate (CAGR) of 4.6% over the forecas...
February 23, 2024
Insight Highlights: The fight against ulcerative colitis is intensifying! The treatment market reached a value of USD 10.16 billion in 2023. It is projected to climb at a 4.1% CAGR, surpassing USD 14 billion by 2033. Pancolitis, affecting the en...